HERITAGE CANNABIS HOLDINGS CORP. (CSE:CANN) (CNSX:CANN.CN) (OTC:HERTF) (“Heritage” or the “Company”) today announced the launch of three Purefarma vape cartridges: Purefarma Sun, Purefarma Moon, and Purefarma Earth.

Sold in the adult-use cannabis market through Voyage Cannabis Corp., a licensed subsidiary of Heritage, Purefarma is the Company’s second major brand rollout. This long-established and much anticipated med/rec brand provides consumers with a formulated full spectrum, direct-to-vape oil which targets users whose primary use of cannabis is for the potential medical benefits they may experience.


Both Purefarma Sun (Sativa properties) and Moon (Indica properties) vape cartridges are made using a carefully managed extraction process using the highest quality, and hand selected cannabis flower. The Purefarma Earth CBD vape cartridge is a true CBD vape and is a unique offering for the initial launch in these markets.

“Featuring premium hardware and packaging, and available to the consumer in the mid $30s range for a 500 mg cartridge, our Purefarma vape cartridges are expected to be well received by our launch markets,” stated Chris Pearson, VP Sales and Marketing of Heritage. “The Purefarma Earth CBD vape cartridge is our most anticipated product launch and we are eager to fulfill the many requests we have been receiving for this distinctive product.”

Purefarma’s proprietary extraction process allows for full plant vapeable products which preserve distinctive flavour expressions without the need for back-added terpenes, flavours, or carrier oil. Formulated for maximum bioavailability Purefarma’s products embody the unique strain specific benefits which are not available in a formulated distillate.

“We have targeted a pricing strategy for our products in order to deliver what consumers have been demanding – high quality products at reasonable prices,” commented Clint Sharples, CEO of Heritage. “At Heritage we are able to deliver this by keeping our fixed costs as low as possible, while eliminating as many traditional manufacturing and distribution costs as we can. Our goal is to deliver strong margins for Heritage, while providing competitively priced high-quality product options to consumers.”

As previously announced, in addition to the launch of Purefarma Sun, Moon and Earth vape cartridges, Heritage will be launching Pura Vida branded full spectrum Sativa, Indica & Hybrid Honey Oil Vape Cartridges, as well as its Pura Vida ‘Daybreak’ and ‘Nightfall’ full spectrum THC Tinctures in the same markets in July, with additional markets expected to follow for all Heritage products.


Click Image To View Full Size

About Heritage Cannabis Holdings Corp.

Heritage Cannabis Holdings Corp. is a vertically integrated cannabis company that owns two Health Canada approved licenced producers, Voyage Cannabis Corp. and CannaCure Corp., both of which also have industrial hemp licenses. Additionally, Voyage recently received its sales license from Health Canada. Working under these licenses, Heritage has two additional subsidiaries, Purefarma Solutions, that provides extraction services, and a Medical Services Division which is focused on cannabis based medical solutions. Heritage as the parent company, provides the synergies and resources for its subsidiaries to advance their medical and adult use products and services both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

“Clint Sharples”

Clint Sharples

CEO

For more information contact:

Clint Sharples

Tel: 416-705-8529

csharples@heritagecann.com

or

Kelly Castledine

Tel: 647-660-2560

kcastledine@heritagecann.com

The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors – including the availability of funds, the results of financing efforts, the results of exploration activities — that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Copyright (c) 2020 TheNewswire – All rights reserved.

TheNewsWire
June 24, 2020 – 4:00 AM PDT
News by QuoteMedia

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less